MLSS Milestone Scientific Dashboard

Milestone Scientific Inc. is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone's proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections.

Company profile

Ticker

MLSS

Exchange

NYSE

Website

www.milestonescientific.com

CEO

Leonard A. Osser

Incorporated

Delaware

Location

New Jersey

Fiscal year end

Dec 31

Sector

Manufacturing > Surgical and Medical Instrument Manufacturing

Industry (SIC)

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Zimmer Biomet • Steris • Avanos Medical • Intuitive Surgical • Edwards Lifesciences • Invacare • MSA Safety • Wright Medical • Align Technology • Surgalign ...

Former names

MILESTONE SCIENTIFIC INC/NJ, U S OPPORTUNITY SEARCH INC

SEC CIK

0000855683

Corporate docs

Articles of Incorporation & Bylaws

IRS number

133545623

MLSS stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

The Daily Biotech Pulse: Pfizer-BioNTech Preps For BLA Filing, Sonoma Surges, BioXcel Readout, Ortho Clinical Lands Contract

1 Apr 21

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 31)

Earnings Scheduled For April 1, 2021

1 Apr 21

Companies Reporting Before The Bell • Agrify (NASDAQ:AGFY) is expected to report quarterly loss at $0.73 per share on revenue of $3.74 million. • Yiren Digital (NYSE:YRD) is likely to report earnings for its fourth quarter.

Milestone Scientific Shares See Volume; Co Granted U.S. Patent Titled 'Device and method for identification of a target region'

30 Mar 21

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=10960141.PN.&OS=PN/10960141&RS=PN/10960141

USPTO Site Shows Milestone Scientific Patent For 'Disposable assembly for drug infusion with pressure sensing for identification of and injection into fluid-filled anatomic spaces'

16 Mar 21

Milestone Scientific To Present At Q1 Virtual Investor Summit Mar. 24

12 Mar 21

Press releases

Pro users get this 30m faster

Milestone Scientific Provides 2020 Year-End Business Update; Reports a 78% Sequential Increase in Revenue for Q4 2020 Versus Q3 2020

1 Apr 21

ROSELAND, N.J., April 01, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a

Milestone Scientific Schedules 2020 Year-End Business Update Conference Call

30 Mar 21

ROSELAND, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today

Milestone Scientific to Present at the Q1 Virtual Investor Summit

12 Mar 21

ROSELAND, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise

Milestone Scientific Receives Notice of Allowance for European Patent Related to Combination of Nerve Stimulation and DPS Dynamic Pressure Sensing Technology® to Optimize Needle Tip Location in Ultrasound-Guided PNB Procedures

10 Mar 21

Milestone Scientific Inc. Commences Sales of CompuFlo® / CathCheck™ Disposables to the Nationally Recognized Medical University of South Carolina

2 Mar 21

Investment data

Data from SEC filings

Securities sold

Number of investors

Calendar

31 Mar 21

13 Apr 21

31 Dec 21

Financial summary

Financial statements Chart MLSS financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 20	Dec 19	Dec 18	Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated)	Burn method: Change in cash		Burn method: Operating income/loss		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	14.22M	14.22M	14.22M	14.22M	14.22M	14.22M
Cash burn (monthly)	75K	(positive/no burn)	398.3K	621.09K	212.92K	582.08K
Cash used (since last report)	257.62K	n/a	1.37M	2.13M	731.41K	2M
Cash remaining	13.97M	n/a	12.86M	12.09M	13.49M	12.22M
Runway (months of cash)	186.2	n/a	32.3	19.5	63.4	21.0

Beta Read what these cash burn values mean

Recent insider trades

MLSS insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
17 Feb 21	Leslie Bernhard	Common Stock, Par Value $0.001	Sell	Dispose S	No	No	3.61	20,000	72.2K	45,000
16 Feb 21	Leslie Bernhard	Common Stock, Par Value $0.001	Sell	Dispose S	No	No	3.87	25,000	96.75K	65,000
11 Feb 21	Giandomenico Trombetta	Common Stock	Sell	Dispose S	No	No	3.85	10,000	38.5K	9,921,039
8 Feb 21	Giandomenico Trombetta	Common Stock	Sell	Dispose S	No	No	3.37	600	2.02K	9,931,039
8 Feb 21	Giandomenico Trombetta	Common Stock	Sell	Dispose S	No	No	3.36	2,216	7.45K	9,931,639
8 Feb 21	Giandomenico Trombetta	Common Stock	Sell	Dispose S	No	No	3.35	7,184	24.07K	9,933,855
4 Feb 21	Giandomenico Trombetta	Common Stock	Sell	Dispose S	No	No	3.2	7,780	24.9K	9,941,039
3 Feb 21	Giandomenico Trombetta	Common Stock	Sell	Dispose S	No	No	3.1	15,000	46.5K	9,948,819
3 Feb 21	Giandomenico Trombetta	Common Stock	Sell	Dispose S	No	No	2.99	14,000	41.86K	9,963,819
3 Feb 21	Giandomenico Trombetta	Common Stock	Sell	Dispose S	No	No	3	1,000	3K	9,978,819

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

MLSS institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

12.7% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	45	44	+2.3%
Opened positions	8	6	+33.3%
Closed positions	7	4	+75.0%
Increased positions	20	13	+53.8%
Reduced positions	7	13	-46.2%

13F shares	Current	Prev Q	Change
Total value	33.98M	22.69M	+49.8%
Total shares	8.42M	7.35M	+14.6%
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Vanguard	2.55M	$5.4M	-2.5%
BLK Blackrock	2.11M	$4.47M	+16.7%
Bridgeway Capital Management	576.1K	$1.22M	+17.8%
STT State Street	542.23K	$1.15M	+61.7%
NTRS Northern Trust	476.59K	$1.01M	+10.5%
Geode Capital Management	472.27K	$1M	+21.2%
swisspartners	251.83K	$525K	NEW
Nuveen Asset Management	209.76K	$445K	+23.4%
Charles Schwab Investment Management	123.32K	$262K	+11.9%
Mercer Global Advisors	117.75K	$250K	0.0%

Largest transactions	Shares	Bought/sold	Change
BLK Blackrock	2.11M	+302.29K	+16.7%
swisspartners	251.83K	+251.83K	NEW
STT State Street	542.23K	+206.92K	+61.7%
Envestnet Asset Management	117.75K	+117.75K	NEW
Squarepoint Ops	17.93K	-116.73K	-86.7%
Bridgeway Capital Management	576.1K	+87.2K	+17.8%
JPM JPMorgan Chase & Co.	116.04K	+86.12K	+287.8%
Geode Capital Management	472.27K	+82.5K	+21.2%
Vanguard	2.55M	-65.22K	-2.5%
WFC Wells Fargo & Co.	27.55K	-55.94K	-67.0%

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: add, addendum, Adriaan, ae, alliance, alter, analyzing, Anhui, Apr, Arjan, bad, Bank, Barcelona, Beijing, categorized, CathCheck, chain, Claudia, CompuPulse, CompuWave, constantly, covid, Creatd, Cresco, cybersecurity, demand, destroyed, dislodged, displaced, dissolved, diverting, economy, elevated, Elkem, enrollment, Etkon, Euroanaesthesia, evolve, evolving, exacerbate, expedient, FDIC, forgiven, globe, goal, heartbeat, hurdle, immigration, intelligence, intraperiod, IP, Jan, Jun, kit, large, led, length, Leyden, loan, LP, Maishida, manual, Mold, molding, mortgage, movement, noncash, Nordic, operatory, oversaw, Paycheck, perioperative, Pharmacy, pick, pool, PPP, pre, precautionary, Premier, prepayment, presence, prototype, pulsatile, rapidly, reached, reaching, recruit, relocation, remotely, reopening, resume, save, Savoy, short, showing, Simplifying, skilled, Spain, Straumann, Subtopic, suffice, surge, surviving, talent, therefrom, thousand, Ti, Title, unproven, USPTO, verification, verify, waveform, workforce, worsen, Xcentric

Removed: accompany, accomplish, advertising, assured, Ave, bulk, button, CA, called, Canadian, capitalized, CCS, CFDA, circumference, collectability, Cornell, CT, cumulative, dba, delisted, domiciled, Edward, embodied, endeavored, exempt, exploring, feeling, feet, formed, fourth, Gale, infiltration, inform, initiate, initiative, Jerrick, Lavin, leasing, mailing, margin, methodology, modification, Ontario, opportunity, Orange, palatal, participation, PC, PDL, pension, perfecting, pilot, pledge, point, pressing, progressed, Proximate, release, replace, screen, secured, Seller, Sinopharm, slight, specialist, Specifically, supportable, targeting, touch, trained, unaffiliated, unaudited, unregistered, usage, vibration, Warren, Zelnick

From filing 10-K 2020 FY